Please download the dossier by clicking on the dossier button x
×

Quinolinyl modulators of RORγt

  • US 10,201,546 B2
  • Filed: 03/02/2017
  • Issued: 02/12/2019
  • Est. Priority Date: 10/15/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating or ameliorating a RORγ

  • t mediated inflammatory syndrome, disorder or disease selected from the group consisting of;

    inflammatory bowel diseases, rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disorder, psoriatic arthritis, ankylosing spondylitis, neutrophilic asthma, steroid resistant asthma, multiple sclerosis, and systemic lupus erythematosus, comprising administering to a subject in need thereof an effective amount of a compound of Formula I, wherein;

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×